Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use

被引:225
作者
Walsh, Zach [1 ]
Callaway, Robert
Belle-Isle, Lynne [2 ,3 ]
Capler, Rielle [4 ]
Kay, Robert [5 ]
Lucas, Philippe [3 ]
Holtzman, Susan [1 ]
机构
[1] Univ British Columbia, Kelowna, BC V1V1V7, Canada
[2] Canadian AIDS Soc, Ottawa, ON K2P2R3, Canada
[3] Ctr Addict Res British Columbia, Victoria, BC V8W 2Y2, Canada
[4] Canadian Assoc Med Cannabis Dispensaries, Lions Bay, BC V0N 2E0, Canada
[5] Green Cannapy Res & Dev, Kelowna, BC V1X 1X7, Canada
关键词
Cannabis; Medical marijuana; Access to cannabis; MEDICAL MARIJUANA; DEPRESSION;
D O I
10.1016/j.drugpo.2013.08.010
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The authorized and unauthorized use of cannabis for therapeutic purposes (CTP) has increased dramatically in recent years, and physicians have called for further research to better clarify the parameters of effective and appropriate use. We report findings from a large cross-sectional study of the use of CTP in Canada and compare use across medical conditions and across authorized and unauthorized users. Methods: We examined cannabis use history, medical conditions and symptoms, patterns of current use of CTP, modes of access and perceived effectiveness among 628 self-selected Canadians consumers of CTP. Participants were recruited from medical cannabis dispensaries and from organizations that assist users of CTP. Results: Patients reported using cannabis to treat multiple symptoms, with sleep, pain, and anxiety being the most common. Cannabis was perceived to provide effective symptoms relief across medical conditions. Patterns of use were also consistent across medical conditions. Notable differences were observed with regard to modes of access. Conclusion: Across medical conditions respondents reported using cannabis to effectively address diverse symptoms. Results indicate a substantial disconnect between the therapeutic use of cannabis and research on the risks and benefits of such use; particularly with regard to the anxiolytic and sedative use of cannabis. Authorized and unauthorized users exhibited few meaningful differences with regard to medical conditions and patterns of use, but faced substantial differences regarding access. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 31 条
[1]  
Abel E., 1980, Marijuana, The First 12,000 Years, DOI 10.1007/978-1-4899-2189-5_1
[2]  
Adlaf E.M., 2005, CANADIAN ADDICTION S
[3]  
[Anonymous], 2011, CAN ALC DRUG US MON
[4]   Barriers to access to medical cannabis for Canadians living with HIV/AIDS [J].
Belle-Isle, L. ;
Hathaway, A. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (04) :500-506
[5]   Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study [J].
Bottorff, Joan L. ;
Bissell, Laura J. L. ;
Balneaves, Lynda G. ;
Oliffe, John L. ;
Capler, N. Rielle ;
Buxton, Jane .
HARM REDUCTION JOURNAL, 2013, 10
[6]   Mary-Jane and her patients: sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents [J].
Braitstein, P ;
Kendall, T ;
Chan, K ;
Wood, E ;
Montaner, JSG ;
O'Shaughnessy, MV ;
Hogg, RS .
AIDS, 2001, 15 (04) :532-533
[7]   DEPRESSION STIGMA, RACE, AND TREATMENT SEEKING BEHAVIOR AND ATTITUDES [J].
Brown, Charlotte ;
Conner, Kyaien O. ;
Copeland, Valire Carr ;
Grote, Nancy ;
Beach, Scott ;
Battista, Deena ;
Reynolds, Charles F., III .
JOURNAL OF COMMUNITY PSYCHOLOGY, 2010, 38 (03) :350-368
[8]  
Canadian Mediical Association, 2012, OUR MEMB VIEWS MED M
[9]   Patterns of cannabis use among patients with multiple sclerosis [J].
Clark, AJ ;
Ware, MA ;
Yazer, E ;
Murray, TJ ;
Lynch, ME .
NEUROLOGY, 2004, 62 (11) :2098-2100
[10]  
Earleywine Mitchell., 2005, Understanding Marijuana: A New Look at the Scientific Evidence